Soft tissue and visceral sarcomas: ESMO–EURACAN–GENTURIS Clinical Practice Guidelines for diagnosis, treatment and follow-up☆Alessandro Gronchi, Silvia Stacchiotti, Javier Martín‐Broto et al.|Annals of Oncology|2021Cited by 978
Gastrointestinal stromal tumours: ESMO–EURACAN–GENTURIS Clinical Practice Guidelines for diagnosis, treatment and follow-upPaolo G. Casali, Silvia Stacchiotti, Carlo Morosi et al.|Annals of Oncology|2021Cited by 558
Development and validation of a prognostic nomogram for recurrence-free survival after complete surgical resection of localised primary gastrointestinal stromal tumour: a retrospective analysisJason S. Gold, Ronald P. DeMatteo, Mithat Gönen et al.|The Lancet Oncology|2009Cited by 511
Pexidartinib versus placebo for advanced tenosynovial giant cell tumour (ENLIVEN): a randomised phase 3 trialWilliam D. Tap, Andrew J. Wagner, Hans Gelderblom et al.|The Lancet|2019Cited by 472
Diagnosis and management of tropomyosin receptor kinase (TRK) fusion sarcomas: expert recommendations from the World Sarcoma NetworkGeorge D. Demetri, Jean‐Yves Blay, Andrew J. Wagner et al.|Annals of Oncology|2020Cited by 145